BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34052822)

  • 1. Value of Early Post-Operative Growth Hormone Testing in Predicting Long-Term Remission and Residual Disease after Transsphenoidal Surgery for Acromegaly.
    Wang YY; Waqar M; Abou-Zeid A; Kearney T; Caputo C; Davis J; Trainer P; Higham C; Roncaroli F; Gnanalingham KK
    Neuroendocrinology; 2022; 112(4):345-357. PubMed ID: 34052822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2010 versus the 2000 consensus criteria in patients with normalised insulin-like growth factor 1 after transsphenoidal surgery has high predictive values for long-term recurrence-free survival in acromegaly.
    Shen M; Chen Z; Shou X; He W; Qiao N; Ma Z; Ye Z; Zhang Y; Zhang Q; Zhou X; Cao X; Zhang Z; Ye H; Li Y; Zhao Y; Li S; He M; Wang Y
    J Neuroendocrinol; 2021 May; 33(5):e12958. PubMed ID: 33998086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early postoperative prediction of both disease remission and long-term disease control in acromegaly using the oral glucose tolerance test.
    Sakata K; Nagata Y; Takeshige N; Kikuchi J; Shikata M; Ashida K; Nomura M; Morioka M
    Hormones (Athens); 2021 Sep; 20(3):515-526. PubMed ID: 33738782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly.
    Serri O; Beauregard C; Hardy J
    J Clin Endocrinol Metab; 2004 Feb; 89(2):658-61. PubMed ID: 14764777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acromegaly surgery in Manchester revisited--the impact of reducing surgeon numbers and the 2010 consensus guidelines for disease remission.
    Wang YY; Higham C; Kearney T; Davis JR; Trainer P; Gnanalingham KK
    Clin Endocrinol (Oxf); 2012 Mar; 76(3):399-406. PubMed ID: 21824170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
    Cardinal T; Rutkowski MJ; Micko A; Shiroishi M; Jason Liu CS; Wrobel B; Carmichael J; Zada G
    Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly.
    Kim EH; Oh MC; Lee EJ; Kim SH
    Neurosurgery; 2012 May; 70(5):1106-13; discussion 1113. PubMed ID: 22067418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can immediate postoperative random growth hormone levels predict long-term cure in patients with acromegaly?
    Dutta P; Korbonits M; Sachdeva N; Gupta P; Srinivasan A; Devgun JS; Bajaj A; Mukherjee KK
    Neurol India; 2016; 64(2):252-8. PubMed ID: 26954802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.
    Colao A; Pivonello R; Cavallo LM; Gaccione M; Auriemma RS; Esposito F; Cappabianca P; Lombardi G
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):250-6. PubMed ID: 16886969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of early postoperative random growth hormone levels and nadir growth hormone levels after oral glucose tolerance testing in acromegaly.
    Rotermund R; Burkhardt T; Rohani Z; Jung R; Aberle J; Flitsch J
    Growth Horm IGF Res; 2018 Aug; 41():64-70. PubMed ID: 29555234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity.
    Elias PC; Lugao HB; Pereira MC; Machado HR; Castro Md; Moreira AC
    Horm Metab Res; 2010 Jan; 42(1):50-5. PubMed ID: 19798623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly.
    Bourdelot A; Coste J; Hazebroucq V; Gaillard S; Cazabat L; Bertagna X; Bertherat J
    Eur J Endocrinol; 2004 Jun; 150(6):763-71. PubMed ID: 15191345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordant growth hormone and IGF-1 levels post pituitary surgery in patients with acromegaly naïve to medical therapy and radiation: what to follow, GH or IGF-1 values?
    Brzana JA; Yedinak CG; Delashaw JB; Gultelkin HS; Cook D; Fleseriu M
    Pituitary; 2012 Dec; 15(4):562-70. PubMed ID: 22183781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative evaluation of patients with acromegaly: clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor I, acid-labile subunit, and growth hormone-binding protein levels.
    Feelders RA; Bidlingmaier M; Strasburger CJ; Janssen JA; Uitterlinden P; Hofland LJ; Lamberts SW; van der Lely AJ; de Herder WW
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6480-9. PubMed ID: 16159936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria.
    Hazer DB; Işık S; Berker D; Güler S; Gürlek A; Yücel T; Berker M
    J Neurosurg; 2013 Dec; 119(6):1467-77. PubMed ID: 24074496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
    Freda PU; Post KD; Powell JS; Wardlaw SL
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?
    Costa AC; Rossi A; Martinelli CE; Machado HR; Moreira AC
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3142-7. PubMed ID: 12107214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of "abnormal" nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels.
    Freda PU; Nuruzzaman AT; Reyes CM; Sundeen RE; Post KD
    J Clin Endocrinol Metab; 2004 Feb; 89(2):495-500. PubMed ID: 14764751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transsphenoidal surgery for acromegaly: predicting remission with early postoperative growth hormone assays.
    Sarkar S; Jacob KS; Pratheesh R; Chacko AG
    Acta Neurochir (Wien); 2014 Jul; 156(7):1379-87; discussion 1387. PubMed ID: 24781680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Outcome of surgical treatment for acromegaly performed by a single neurosurgeon and cumulative meta-analysis].
    Boeving A; Borba LA; Rodrigues AM; Orichowski EB; Paz Filho GJ; Santos CM; Boguszewski CL
    Arq Bras Endocrinol Metabol; 2006 Oct; 50(5):884-92. PubMed ID: 17160212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.